1-((8R,9S,13S,14S,17S)-13-methyl-3-(3-((R)-2-methylpyrrolidin-1-yl)propoxy)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-17-yl)pyrrolidin-2-one

ID: ALA4593317

Chembl Id: CHEMBL4593317

PubChem CID: 155569335

Max Phase: Preclinical

Molecular Formula: C30H44N2O2

Molecular Weight: 464.69

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  C[C@@H]1CCCN1CCCOc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](N3CCCC3=O)CC[C@@H]12

Standard InChI:  InChI=1S/C30H44N2O2/c1-21-6-3-16-31(21)17-5-19-34-23-9-11-24-22(20-23)8-10-26-25(24)14-15-30(2)27(26)12-13-28(30)32-18-4-7-29(32)33/h9,11,20-21,25-28H,3-8,10,12-19H2,1-2H3/t21-,25-,26-,27+,28+,30+/m1/s1

Standard InChI Key:  YNGGXQWHLXCXBQ-OJYLLFOJSA-N

Alternative Forms

  1. Parent:

    ALA4593317

    ---

Associated Targets(non-human)

Hrh3 Histamine H3 receptor (2579 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Chrm1 Muscarinic acetylcholine receptor (3770 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 464.69Molecular Weight (Monoisotopic): 464.3403AlogP: 5.79#Rotatable Bonds: 6
Polar Surface Area: 32.78Molecular Species: BASEHBA: 3HBD:
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 9.72CX LogP: 4.96CX LogD: 2.66
Aromatic Rings: 1Heavy Atoms: 34QED Weighted: 0.50Np Likeness Score: 0.48

References

1. Ledneczki I, Némethy Z, Tapolcsányi P, Éles J, Greiner I, Gábor E, Varga B, Balázs O, Román V, Lévay G, Mahó S..  (2019)  Discovery of novel steroidal histamine H3 receptor antagonists/inverse agonists. Part 2. Versatile steroidal carboxamide derivatives.,  29  (20): [PMID:31492518] [10.1016/j.bmcl.2019.126643]

Source